These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

663 related items for PubMed ID: 15200348

  • 1. The role of sulphonylureas in the management of type 2 diabetes mellitus.
    Rendell M.
    Drugs; 2004; 64(12):1339-58. PubMed ID: 15200348
    [Abstract] [Full Text] [Related]

  • 2. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ, Bailey CJ.
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [Abstract] [Full Text] [Related]

  • 3. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL, Figgitt DP.
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [Abstract] [Full Text] [Related]

  • 4. Glimepiride. A review of its use in the management of type 2 diabetes mellitus.
    Langtry HD, Balfour JA.
    Drugs; 1998 Apr; 55(4):563-84. PubMed ID: 9561345
    [Abstract] [Full Text] [Related]

  • 5. The use of sulphonylureas in the elderly.
    Graal MB, Wolffenbuttel BH.
    Drugs Aging; 1999 Dec; 15(6):471-81. PubMed ID: 10641958
    [Abstract] [Full Text] [Related]

  • 6. Drug interactions of clinical importance with antihyperglycaemic agents: an update.
    Scheen AJ.
    Drug Saf; 2005 Dec; 28(7):601-31. PubMed ID: 15963007
    [Abstract] [Full Text] [Related]

  • 7. Meglitinide analogues in the treatment of type 2 diabetes mellitus.
    Landgraf R.
    Drugs Aging; 2000 Nov; 17(5):411-25. PubMed ID: 11190420
    [Abstract] [Full Text] [Related]

  • 8. Comparative tolerability of sulphonylureas in diabetes mellitus.
    Harrower AD.
    Drug Saf; 2000 Apr; 22(4):313-20. PubMed ID: 10789825
    [Abstract] [Full Text] [Related]

  • 9. Second line therapy: type 2 diabetic subjects failing on metformin GLP-1/DPP-IV inhibitors versus sulphonylurea/insulin: for GLP-1/DPP-IV inhibitors.
    Kumar A.
    Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():21-5. PubMed ID: 23280862
    [Abstract] [Full Text] [Related]

  • 10. Comparative tolerability profiles of oral antidiabetic agents.
    Krentz AJ, Ferner RE, Bailey CJ.
    Drug Saf; 1994 Oct; 11(4):223-41. PubMed ID: 7848543
    [Abstract] [Full Text] [Related]

  • 11. Controversies in management of diabetes in patients with coronary heart disease.
    Abdella NA.
    Med Princ Pract; 2002 Oct; 11 Suppl 2():69-74. PubMed ID: 12444313
    [Abstract] [Full Text] [Related]

  • 12. Oral antihyperglycaemics. Considerations in older patients with non-insulin-dependent diabetes mellitus.
    Jennings PE.
    Drugs Aging; 1997 May; 10(5):323-31. PubMed ID: 9143853
    [Abstract] [Full Text] [Related]

  • 13. Oral antidiabetic drugs: an overview.
    Melander A.
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S143-7. PubMed ID: 8894498
    [Abstract] [Full Text] [Related]

  • 14. Mortality outcomes of different sulphonylurea drugs: the results of a 14-year cohort study of type 2 diabetic patients.
    Bo S, Castiglione A, Ghigo E, Gentile L, Durazzo M, Cavallo-Perin P, Ciccone G.
    Eur J Endocrinol; 2013 Jul; 169(1):117-26. PubMed ID: 23660643
    [Abstract] [Full Text] [Related]

  • 15. Risk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: population based cohort study.
    van Dalem J, Brouwers MC, Stehouwer CD, Krings A, Leufkens HG, Driessen JH, de Vries F, Burden AM.
    BMJ; 2016 Jul 13; 354():i3625. PubMed ID: 27413017
    [Abstract] [Full Text] [Related]

  • 16. Clinical review of glimepiride.
    McCall AL.
    Expert Opin Pharmacother; 2001 Apr 13; 2(4):699-713. PubMed ID: 11336617
    [Abstract] [Full Text] [Related]

  • 17. Effect of once-daily insulin detemir on oral antidiabetic drug (OAD) use in patients with type 2 diabetes.
    Vora J, Caputo S, Damci T, Orozco-Beltran D, Pan C, Svendsen AL, Sølje KS, Khunti K, SOLVE study group.
    J Clin Pharm Ther; 2014 Apr 13; 39(2):136-43. PubMed ID: 24329524
    [Abstract] [Full Text] [Related]

  • 18. Mortality risk with sulphonylureas compared to metformin.
    Holden SE, Currie CJ.
    Diabetes Obes Metab; 2014 Oct 13; 16(10):885-90. PubMed ID: 24533964
    [Abstract] [Full Text] [Related]

  • 19. Management of antidiabetic medications in overdose.
    Spiller HA.
    Drug Saf; 1998 Nov 13; 19(5):411-24. PubMed ID: 9825953
    [Abstract] [Full Text] [Related]

  • 20. [Present status in the treatment of type 2 diabetes mellitus. Insulin-secreting agents].
    Blicklé JF, Andres E, Neyrolles N, Brogard JM.
    Rev Med Interne; 1999 Aug 13; 20 Suppl 3():351s-359s. PubMed ID: 10480186
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.